Schedule 13G ownership disclosure

Axsome Therapeutics Inc

Security class unavailable · CUSIP: 05464T104

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,239,746
Percent of class
6.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001086364-24-004823
Form type
SC 13G/A
Filer
Axsome Therapeutics, Inc.
CIK
CIK 1579428
Filed
Jan 26, 2024
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub